Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094168063> ?p ?o ?g. }
- W2094168063 endingPage "758" @default.
- W2094168063 startingPage "747" @default.
- W2094168063 abstract "X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder caused by mutations in the ABCD1 gene. Accumulation of very long chain fatty acids (VLCFA) that have been attributed to reduced peroxisomal VLCFA β-oxidation activity are the hallmark of the disease. Overexpression of ABCD2 gene, the closest homolog of ABCD1, has been shown to compensate for ABCD1, thus correcting the VLCFA derangement. The accumulation of VLCFA leads to a neuroinflammatory disease process associated with demyelination of the cerebral white matter. The present study underlines the importance of caffeic acid phenethyl ester (CAPE) in inducing the expression of ABCD2 (ALDRP), and normalizing the peroxisomal β-oxidation as well as the levels of saturated and monounsaturated VLCFAs in cultured human skin fibroblasts of X-ALD patients. The expression of ELOVL1, the single elongase catalyzing the synthesis of both saturated VLCFA (C26:0) and mono-unsaturated VLCFA (C26:1), was also reduced by CAPE treatment. Importantly, CAPE upregulated Abcd2 expression and peroxisomal β-oxidation and lowered the VLCFA levels in Abcd1-deficient U87 astrocytes and B12 oligodendrocytes. In addition, using Abcd1/Abcd2-silenced mouse primary astrocytes we examined the effects of CAPE in VLCFA-induced inflammatory response. CAPE treatment decreased the inflammatory response as the expression of inducible nitric oxide synthase, inflammatory cytokine, and activation of NF-κB in Abcd1/Abcd2-silenced mouse primary astrocytes was reduced. The observations indicate that CAPE corrects both the metabolic disease of VLCFA as well as secondary inflammatory disease; therefore, it may be a potential drug candidate to be tested for X-ALD therapy in humans." @default.
- W2094168063 created "2016-06-24" @default.
- W2094168063 creator A5032747758 @default.
- W2094168063 creator A5044613830 @default.
- W2094168063 creator A5059417874 @default.
- W2094168063 date "2013-04-01" @default.
- W2094168063 modified "2023-10-04" @default.
- W2094168063 title "Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes" @default.
- W2094168063 cites W1617969396 @default.
- W2094168063 cites W1801364512 @default.
- W2094168063 cites W1871287341 @default.
- W2094168063 cites W1924236635 @default.
- W2094168063 cites W1964164432 @default.
- W2094168063 cites W1968155533 @default.
- W2094168063 cites W1976030819 @default.
- W2094168063 cites W1983767873 @default.
- W2094168063 cites W1984539455 @default.
- W2094168063 cites W1990045070 @default.
- W2094168063 cites W1991664740 @default.
- W2094168063 cites W1992853235 @default.
- W2094168063 cites W1995735695 @default.
- W2094168063 cites W1996165453 @default.
- W2094168063 cites W1997047641 @default.
- W2094168063 cites W2008237894 @default.
- W2094168063 cites W2010687728 @default.
- W2094168063 cites W2013590942 @default.
- W2094168063 cites W2015428362 @default.
- W2094168063 cites W2015577087 @default.
- W2094168063 cites W2017358216 @default.
- W2094168063 cites W2017641703 @default.
- W2094168063 cites W2018016330 @default.
- W2094168063 cites W2020287578 @default.
- W2094168063 cites W2022057737 @default.
- W2094168063 cites W2023549144 @default.
- W2094168063 cites W2024607954 @default.
- W2094168063 cites W2031846652 @default.
- W2094168063 cites W2035026471 @default.
- W2094168063 cites W2035088045 @default.
- W2094168063 cites W2038699216 @default.
- W2094168063 cites W2040022730 @default.
- W2094168063 cites W2043289191 @default.
- W2094168063 cites W2043614399 @default.
- W2094168063 cites W2044929463 @default.
- W2094168063 cites W2049382351 @default.
- W2094168063 cites W2050783692 @default.
- W2094168063 cites W2052076161 @default.
- W2094168063 cites W2052573968 @default.
- W2094168063 cites W2055909046 @default.
- W2094168063 cites W2064691836 @default.
- W2094168063 cites W2067124986 @default.
- W2094168063 cites W2070923978 @default.
- W2094168063 cites W2074102728 @default.
- W2094168063 cites W2078576948 @default.
- W2094168063 cites W2079075112 @default.
- W2094168063 cites W2081120437 @default.
- W2094168063 cites W2083177766 @default.
- W2094168063 cites W2085894877 @default.
- W2094168063 cites W2089183200 @default.
- W2094168063 cites W2095718298 @default.
- W2094168063 cites W2099862428 @default.
- W2094168063 cites W2103265666 @default.
- W2094168063 cites W2104564418 @default.
- W2094168063 cites W2111220794 @default.
- W2094168063 cites W2112446544 @default.
- W2094168063 cites W2124230153 @default.
- W2094168063 cites W2124546457 @default.
- W2094168063 cites W2130815938 @default.
- W2094168063 cites W2135684554 @default.
- W2094168063 cites W2141570423 @default.
- W2094168063 cites W2147955643 @default.
- W2094168063 cites W2160003319 @default.
- W2094168063 cites W2165825213 @default.
- W2094168063 cites W2167261850 @default.
- W2094168063 cites W2168163415 @default.
- W2094168063 cites W2168710549 @default.
- W2094168063 doi "https://doi.org/10.1016/j.bbalip.2013.01.004" @default.
- W2094168063 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3607212" @default.
- W2094168063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23318275" @default.
- W2094168063 hasPublicationYear "2013" @default.
- W2094168063 type Work @default.
- W2094168063 sameAs 2094168063 @default.
- W2094168063 citedByCount "16" @default.
- W2094168063 countsByYear W20941680632013 @default.
- W2094168063 countsByYear W20941680632014 @default.
- W2094168063 countsByYear W20941680632015 @default.
- W2094168063 countsByYear W20941680632016 @default.
- W2094168063 countsByYear W20941680632017 @default.
- W2094168063 countsByYear W20941680632018 @default.
- W2094168063 countsByYear W20941680632021 @default.
- W2094168063 countsByYear W20941680632023 @default.
- W2094168063 crossrefType "journal-article" @default.
- W2094168063 hasAuthorship W2094168063A5032747758 @default.
- W2094168063 hasAuthorship W2094168063A5044613830 @default.
- W2094168063 hasAuthorship W2094168063A5059417874 @default.
- W2094168063 hasBestOaLocation W20941680632 @default.
- W2094168063 hasConcept C104317684 @default.
- W2094168063 hasConcept C126322002 @default.
- W2094168063 hasConcept C127078168 @default.